New 100-week data from the ongoing Phase I/II study of zigakibart, an investigational anti-APRIL monoclonal antibody, ...

Despite years of patient complaints and quality-of-care concerns, Ballad Health—the nation's largest state-sanctioned ...

A major international study presented at the 62nd ERA Congress reveals that the long-accepted survival advantage of ...

New research from medical students and faculty members associated with the University of Colorado School of Medicine at ...

This fall, researchers from The University of Texas at Arlington will launch an ambitious study to explore how teens' ...

The largest diphtheria outbreak to strike Western Europe in 70 years has been affecting vulnerable people such as migrants ...

A baby's makeup of gut bacteria—their microbiome—which starts to form as soon as they are born, could help protect against ...

A study published in the New England Journal of Medicine reveals that the largest diphtheria epidemic in Western Europe for ...

While many people with neuromuscular diseases currently face a future without a cure, a new study finds that a personalized ...

A study of almost 1,000 pregnant women in Zimbabwe found that a daily dose of a commonly used, safe and inexpensive ...

Researchers at Stanford have developed a new technology for removing blood clots that is more than twice as effective as ...

Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of ...